Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameXunfeihealth
Stock Code02506
Company Full NameXunfei Healthcare Technology Co., Ltd.
Industry軟件服務
Principal Activities公司是一家人工智能賦能的醫療解決方案提供商。
Listing Date2024-12-30
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市西城區廣安門內大街167號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.iflyhealth.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 82.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size50 shares
Entry ThresholdHK$ 4,140
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering Shares7,035,550 shares
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share47.5%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 582,543,540

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 50 HK$ 4,140
2 lots 100 HK$ 8,280
3 lots 150 HK$ 12,420
4 lots 200 HK$ 16,560
5 lots 250 HK$ 20,700
6 lots 300 HK$ 24,840
7 lots 350 HK$ 28,980
8 lots 400 HK$ 33,120
9 lots 450 HK$ 37,260
10 lots 500 HK$ 41,400
12 lots 600 HK$ 49,680
14 lots 700 HK$ 57,960
16 lots 800 HK$ 66,240
18 lots 900 HK$ 74,520
20 lots 1,000 HK$ 82,800
30 lots 1,500 HK$ 124,200
40 lots 2,000 HK$ 165,600
50 lots 2,500 HK$ 207,000
60 lots 3,000 HK$ 248,400
70 lots 3,500 HK$ 289,800
80 lots 4,000 HK$ 331,200
90 lots 4,500 HK$ 372,600
100 lots 5,000 HK$ 414,000
120 lots 6,000 HK$ 496,800
140 lots 7,000 HK$ 579,600
160 lots 8,000 HK$ 662,400
180 lots 9,000 HK$ 745,200
200 lots 10,000 HK$ 828,000
400 lots 20,000 HK$ 1,656,000
600 lots 30,000 HK$ 2,484,000
800 lots 40,000 HK$ 3,312,000
1,000 lots 50,000 HK$ 4,140,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,400 lots 70,000 HK$ 5,796,000
1,600 lots 80,000 HK$ 6,624,000
1,800 lots 90,000 HK$ 7,452,000
2,000 lots 100,000 HK$ 8,280,000
4,000 lots 200,000 HK$ 16,560,000
7,036 lots 351,800 HK$ 29,129,040

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 5.73B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceRMB 142.5 million
Listing Expenses~HK$ 75,400,000
Listing Expenses / Funds Raised~12.94%
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 87.0
First Day OpenHK$ 89.75
First Day Change5.07%
First Day Volume520446.0
First Day Turnover45709400.0
Use of Proceeds
1、約32.4%(即164.0百萬港元)將用于投資研發,以不斷加強公司的核心能力; 2、約26.6%(即135.0百萬港元)將用于通過升級現有產品及開發新產品進一步豐富公司的產品及服務; 3、約24.7%(即125.1百萬港元)將用于加強商業化能力并擴展公司的服務網絡; 4、約6.4%(即32.3百萬港元)將用于收購可能與公司現有產能產生協同效應的公司; 5、約10.0%(即50.7百萬港元)將用于營運資金及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发融资(香港)有限公司 CE AOB163 建银国际金融有限公司 CE AJO225
Sponsor cum Overall Coordinator (1)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Overall Coordinators (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发证券(香港)经纪有限公司 CE AOB364 建银国际金融有限公司 CE AJO225
Joint Global Coordinators (3)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发证券(香港)经纪有限公司 CE AOB364 建银国际金融有限公司 CE AJO225
Joint Bookrunners (9)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发证券(香港)经纪有限公司 CE AOB364 建银国际金融有限公司 CE AJO225 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 SPDB International Capital Limited CE BFZ375 民银证券有限公司 CE APU820 农银国际融资有限公司 CE AWL249 中国银河国际证券(香港)有限公司 CE AXM459 TradeGo Markets Limited CE BRO637
Joint Lead Managers (10)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发证券(香港)经纪有限公司 CE AOB364 建银国际金融有限公司 CE AJO225 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 SPDB International Capital Limited CE BFZ375 民银证券有限公司 CE APU820 农银国际证券有限公司 CE ACX411 中国银河国际证券(香港)有限公司 CE AXM459 TradeGo Markets Limited CE BRO637 Advent Securities (Hong Kong) Limited CE BIC431
Capital Market Intermediaries (11)
HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 广发证券(香港)经纪有限公司 CE AOB364 建银国际金融有限公司 CE AJO225 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 SPDB International Capital Limited CE BFZ375 民银证券有限公司 CE APU820 农银国际融资有限公司 CE AWL249 农银国际证券有限公司 CE ACX411 中国银河国际证券(香港)有限公司 CE AXM459 TradeGo Markets Limited CE BRO637 Advent Securities (Hong Kong) Limited CE BIC431

Service Providers

RoleInstitution
Legal Advisor to Company Clifford Chance
上海澄明则正律师事务所
Pillsbury Winthrop Shaw Pittman LLP
Legal Advisor to Sponsors/Underwriters 欧华律师事务所
金杜律师事务所
Auditor and Reporting Accountant 德勤•关黄陈方会计师行
Industry Advisor 弗若斯特沙利文(北京)咨询有限公司上海分公司
Compliance Advisor Somerley Capital Limited CE BAU754
Receiving Banks 招商永隆银行有限公司

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Costone China Growth Capital I L.P. 62,240,760 HKD — 10.68% — 6 months 2025-06-30
2 达安投资有限公司 62,240,760 HKD — 10.68% — 6 months 2025-06-30
3 横琴粤澳深度合作区产业投资基金(有限合伙) 62,240,760 HKD — 10.68% — 6 months 2025-06-30
4 星群有限公司 27,998,820 HKD — 4.81% — 6 months 2025-06-30
5 讯医有限公司 61,996,500 HKD — 10.64% — 6 months 2025-06-30

Directors & Management

PositionChinese nameEnglish Name
Chairman劉慶峰—
Company Secretary劉偉;楊兆琳—
No director data available.

Major Shareholders

Major Shareholders & Holdings科大訊飛股份有限公司(49.42%),合肥正升信息科技合伙企業(有限合伙)(16.11%),安徽科訊創業投資基金合伙企業(有限合伙)(14.43%)
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.

Market Sentiment

The IPO saw tepid retail demand with an oversubscription ratio of just 3.66 times, far below typical Hong Kong market enthusiasm. This resulted in a hit rate of 89.99% (2,822 of 3,136 applications accepted), meaning nearly all applicants received shares. Such high allocation probability signals weak aftermarket sentiment expectations. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

An inefficiency appeared at the A/B boundary: the last A-tier application (50,000 lots) expected 1 lot, identical to the first B-tier application (70,000 lots). The extra 20,000 lots in B-head yielded no additional allocation, making A-tail more capital efficient. Broker fee considerations may further favor lower-tier applications, though actual costs vary. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Mainland participants overwhelmingly dominated, comprising 82.4% of the 2,709 holders, highlighting strong domestic recognition for the AI healthcare brand. The investor base skewed male (63.8%) with an average age of 42.2, typical of tech-focused IPOs targeting experienced retail investors. Hong Kong residents accounted for just 17.2% of the total. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Xunfeihealth (02506) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect